3 December 2018 - Deborah Wilkes
Archived
Unilever is acquiring a portfolio of consumer healthcare nutrition products, including Horlicks, from GlaxoSmithKline (GSK) in a deal worth EUR3.3 billion (USD3.8 billion).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.